Pat Cotroneo
Net Worth

Last updated:

What is Pat Cotroneo net worth?

The estimated net worth of Mr. Pat Cotroneo is at least $30,330,166 as of 15 Jun 2021. He owns shares worth $3,015,779 as insider, has earned $19,335,387 from insider trading and has received compensation worth at least $7,979,000 in FibroGen, Inc..

What is the salary of Pat Cotroneo?

Mr. Pat Cotroneo salary is $797,900 per year as Executive Advisor to Chief Executive Officer in FibroGen, Inc..

How old is Pat Cotroneo?

Mr. Pat Cotroneo is 61 years old, born in 1964.

What stocks does Pat Cotroneo currently own?

As insider, Mr. Pat Cotroneo owns shares in one company:

Company Title Shares Price per share Total value
FibroGen, Inc. (FGEN) Executive Advisor to Chief Executive Officer 276,677 $10.9 $3,015,779

What does FibroGen, Inc. do?

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China for anemia associated with myelodysplastic syndromes. It is also developing Pamrevlumab, a human monoclonal antibody that inhibits the activity of connective tissue growth factor that is in Phase III clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, liver fibrosis, and diabetic kidney disease, as well as Phase III trial for the treatment of Duchenne muscular dystrophy. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.

FGEN logo
FGEN
FibroGen, Inc.
$10.9

Pat Cotroneo insider trading

FibroGen, Inc.

Mr. Pat Cotroneo has made 51 insider trades between 2015-2021, according to the Form 4 filled with the SEC. Most recently he sold 4,053 units of FGEN stock on 15 Jun 2021.

The largest trade he's ever made was exercising 95,000 units of FGEN stock on 8 Aug 2017. As of 15 Jun 2021 he still owns at least 276,677 units of FGEN stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 4,053 N/A N/A
Sale
Common Stock 3,068 N/A N/A
Sale
Common Stock 3,070 N/A N/A
Option
Stock Option (Right to Buy) 15,004 N/A N/A
Option
Common Stock 15,004 N/A N/A
Sale
Common Stock 15,004 N/A N/A
Option
Stock Option (Right to Buy) 15,004 $24.82 $372,354
Option
Stock Option (Right to Buy) 15,004 N/A N/A
Option
Stock Option (Right to Buy) 7,250 N/A N/A
Option
Common Stock 7,250 N/A N/A
Option
Stock Option (Right to Buy) 22,554 N/A N/A
Sale
Common Stock 22,554 N/A N/A
Option
Common Stock 22,554 N/A N/A
Sale
Common Stock 3,928 $39.68 $155,863
Sale
Common Stock 9,239 $26.36 $243,540
Sale
Common Stock 59,456 $45.89 $2,728,436
Option
Common Stock 56,254 $8.01 $450,482
Option
Stock Option (Right to Buy) 18,000 $3.5 $63,000
Option
Common Stock 12,500 $2.9 $36,250
Option
Stock Option (Right to Buy) 12,500 $2.9 $36,250
Sale
Common Stock 3,201 $41.38 $132,457
Sale
Common Stock 3,201 $43.12 $138,027
Option
Common Stock 7,000 $2.9 $20,300
Option
Stock Option (Right to Buy) 7,000 $2.9 $20,300
Option
Common Stock 10,000 $2.9 $29,000
Option
Stock Option (Right to Buy) 10,000 $2.9 $29,000
Sale
Common Stock 7,665 $55.41 $424,718
Option
Stock Option (Right to Buy) 14,787 $29.66 $438,582
Option
Common Stock 14,787 $29.66 $438,582
Sale
Common Stock 14,787 $29.66 $438,582
Sale
Common Stock 3,330 $41.1 $136,863
Sale
Common Stock 2,318 $59.5 $137,921
Option
Stock Option (Right to Buy) 10,500 $2.9 $30,450
Option
Common Stock 10,500 $2.9 $30,450
Sale
Common Stock 1,011 $57.35 $57,981
Sale
Common Stock 7,750 $25.4 $196,850
Option
Stock Option (Right to Buy) 7,750 $25.4 $196,850
Option
Common Stock 7,750 $25.4 $196,850
Sale
Common Stock 2,319 $57.7 $133,806
Sale
Common Stock 1,011 $55.55 $56,161
Option
Stock Option (Right to Buy) 6,013 $19.39 $116,592
Sale
Common Stock 6,013 $19.39 $116,592
Option
Common Stock 6,013 $19.39 $116,592
Option
Stock Option (Right to Buy) 14,987 $22.4 $335,634
Sale
Common Stock 14,987 $55.04 $824,884
Option
Common Stock 14,987 $22.4 $335,634
Option
Stock Option (Right to Buy) 1,550 $2.9 $4,495
Option
Common Stock 33,550 $2.9 $97,295
Sale
Common Stock 36,094 $52.66 $1,900,530
Option
Common Stock 36,094 $24.53 $885,205
Option
Stock Option (Right to Buy) 36,094 $24.53 $885,205
Sale
Common Stock 5,932 $54.61 $323,947
Sale
Common Stock 1,894 $53.53 $101,392
Option
Common Stock 3,960 $18 $71,280
Option
Stock Option (Right to Buy) 3,960 $18 $71,280
Sale
Common Stock 3,960 $56.48 $223,661
Sale
Common Stock 45,540 $55.77 $2,539,766
Option
Common Stock 45,540 $23.83 $1,085,218
Option
Stock Option (Right to Buy) 45,540 $23.83 $1,085,218
Option
Stock Option (Right to Buy) 25,000 $18 $450,000
Sale
Common Stock 25,000 $48.7 $1,217,375
Option
Common Stock 25,000 $18 $450,000
Sale
Common Stock 2,851 $46 $131,146
Option
Common Stock 32,407 $2.9 $93,980
Option
Stock Option (Right to Buy) 10,807 $1.45 $15,670
Sale
Common Stock 2,851 $49.45 $140,982
Option
Stock Option (Right to Buy) 95,000 $9.04 $858,610
Option
Common Stock 95,000 $9.04 $858,610
Sale
Common Stock 95,000 $50.56 $4,802,915
Option
Common Stock 20,746 $8.74 $181,258
Option
Stock Option (Right to Buy) 20,746 $8.74 $181,258
Sale
Common Stock 20,746 $34.13 $708,061
Option
Common Stock 7,600 $8.74 $66,401
Sale
Common Stock 7,600 $33.54 $254,904
Option
Stock Option (Right to Buy) 7,600 $8.74 $66,401
Option
Stock Option (Right to Buy) 4,000 $2.9 $11,600
Option
Common Stock 4,000 $2.9 $11,600
Sale
Common Stock 4,000 $2.9 $11,600
Option
Common Stock 3,000 $2.9 $8,700
Sale
Common Stock 3,000 $2.9 $8,700
Option
Stock Option (Right to Buy) 3,000 $2.9 $8,700
Sale
Common Stock 5,500 $2.35 $12,925
Option
Common Stock 5,500 $2.35 $12,925
Option
Stock Option (Right to Buy) 5,500 $2.35 $12,925
Sale
Common Stock 2,891 $28.75 $83,116
Option
Stock Option (Right to Buy) 10,000 $2.9 $29,000
Option
Common Stock 10,000 $2.9 $29,000
Sale
Common Stock 6,500 $2.35 $15,275
Option
Common Stock 6,500 $2.35 $15,275
Option
Stock Option (Right to Buy) 6,500 $2.35 $15,275
Sale
Common Stock 7,851 $25.3 $198,630
Sale
Common Stock 5,600 $26 $145,600
Option
Stock Option (Right to Buy) 5,600 $26 $145,600
Option
Common Stock 5,600 $26 $145,600
Sale
Common Stock 900 $2.35 $2,115
Option
Stock Option (Right to Buy) 900 $2.35 $2,115
Option
Common Stock 900 $2.35 $2,115
Sale
Common Stock 6,500 $2.35 $15,275
Option
Stock Option (Right to Buy) 6,500 $2.35 $15,275
Option
Common Stock 6,500 $2.35 $15,275
Sale
Common Stock 2,344 $22.05 $51,685
Option
Stock Option (Right to Buy) 1,643 $2.9 $4,765
Option
Common Stock 1,643 $2.9 $4,765
Sale
Common Stock 2,345 $18.22 $42,726
Sale
Common Stock 1,796 $16.49 $29,616
Sale
Common Stock 6,107 $17.6 $107,483
Option
Common Stock 3,627 $2.9 $10,518
Option
Stock Option (Right to Buy) 3,100 $2.9 $8,990
Option
Stock Option (Right to Buy) 4,000 $1.45 $5,800
Option
Common Stock 4,000 $2.9 $11,600
Sale
Common Stock 837 $28.95 $24,231
Option
Common Stock 1,300 $2.9 $3,770
Option
Stock Option (Right to Buy) 1,300 $2.9 $3,770
Option
Stock Option (Right to Buy) 5,000 $2.35 $11,750
Sale
Common Stock 5,000 $2.35 $11,750
Option
Common Stock 5,000 $2.35 $11,750
Sale
Common Stock 1,093 $27.95 $30,549
Option
Common Stock 1,340 $2.9 $3,886
Option
Stock Option (Right to Buy) 5,000 N/A N/A
Sale
Common Stock 5,000 $28 $140,000
Option
Common Stock 5,000 $28 $140,000
Option
Common Stock 3,190 $2.63 $8,374
Sale
Common Stock 2,500 $2.35 $5,875
Option
Stock Option (Right to Buy) 4,530 $1.31 $5,948
Option
Stock Option (Right to Buy) 1,400 $1.45 $2,030
Option
Common Stock 1,400 $2.9 $4,060
Sale
Common Stock 2,500 $2.35 $5,875
Option
Common Stock 2,500 $2.35 $5,875
Option
Stock Option (Right to Buy) 2,500 $2.35 $5,875
Sale
Common Stock 5,381 $23.23 $125,001
Option
Common Stock 12,000 $2.9 $34,800
Option
Stock Option (Right to Buy) 12,000 $1.45 $17,400

FibroGen key executives

FibroGen, Inc. executives and other stock owners filed with the SEC: